{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T23:13:54Z","timestamp":1794698034459,"version":"4.9.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ejpn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ejpn.2015.07.009","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T17:33:00Z","timestamp":1437413580000},"page":"652-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis"],"prefix":"10.1016","volume":"19","author":[{"given":"M.L.","family":"Couce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Meavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"B\u00f3veda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fern\u00e1ndez-Marmiesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garc\u00eda-Cazorla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2015.07.009_bib1","series-title":"The metabolic and molecular basis of inherited disease","first-page":"1971","article-title":"Maple syrup urine disease (branched-chain ketoaciduria)","author":"Chuang","year":"2001"},{"key":"10.1016\/j.ejpn.2015.07.009_bib2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00431-003-1282-z","article-title":"Leigh syndrome due to compound heterozygosity of dihydrolipoamide dehydrogenase gene mutations. Description of the first E3 splice site mutation","volume":"162","author":"Grafakou","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ejpn.2015.07.009_bib3","series-title":"GeneReviews","first-page":"1993","article-title":"Maple syrup urine disease","author":"Strauss","year":"2006"},{"key":"10.1016\/j.ejpn.2015.07.009_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","article-title":"Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach","volume":"112","author":"Frazier","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejpn.2015.07.009_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/hmg\/ddq507","article-title":"Phenylbutyrate therapy for maple syrup urine disease","volume":"20","author":"Brunetti-Pierri","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejpn.2015.07.009_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpeds.2011.06.033","article-title":"Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and Comparative United Network for Organ Sharing experience","volume":"160","author":"Mazariegos","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejpn.2015.07.009_bib7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/MPG.0000000000000469","article-title":"Liver transplantation for classical maple syrup urine disease: long-term follow-up","volume":"59","author":"D\u00edaz","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ejpn.2015.07.009_bib8","doi-asserted-by":"crossref","first-page":"1531S","DOI":"10.1093\/jn\/135.6.1531S","article-title":"Brain amino acid requirements and toxicity: the example of leucine","volume":"135","author":"Yudkoff","year":"2005","journal-title":"J Nutr"},{"key":"10.1016\/j.ejpn.2015.07.009_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0009-8981(78)90433-3","article-title":"Correlations between branched-chain amino acids and branched-chain alpha-keto acids in blood in maple syrup urine disease","volume":"88","author":"Langenbeck","year":"1978","journal-title":"Clin Chim Acta"},{"issue":"Pt 4","key":"10.1016\/j.ejpn.2015.07.009_bib10","first-page":"903","article-title":"Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease","volume":"132","author":"Zinnanti","year":"2009","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ejpn.2015.07.009_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10571-013-0002-0","article-title":"Neurological damage in MSUD: the role of oxidative stress","volume":"34","author":"Sitta","year":"2014","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.ejpn.2015.07.009_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11011-007-9077-y","article-title":"Oxidative stress in plasma from maple syrup urine disease patients during treatment","volume":"23","author":"Barschak","year":"2008","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.ejpn.2015.07.009_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12035-013-8447-1","article-title":"Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus","volume":"48","author":"Scaini","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.ejpn.2015.07.009_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ajmg.c.20003","article-title":"Genetic heritage of the Old Order Mennonites of southeastern Pennsylvania","volume":"121C","author":"Puffenberger","year":"2003","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.ejpn.2015.07.009_bib15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1542\/peds.109.6.999","article-title":"Diagnosis and treatment of maple syrup disease: a study of 36 patients","volume":"109","author":"Morton","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpn.2015.07.009_bib16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ymgme.2011.09.021","article-title":"Evaluation and long-term follow-up of infants with inborn errors of metabolism","volume":"104","author":"Couce","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejpn.2015.07.009_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.gene.2012.01.082","article-title":"Two novel mutations in the BCKDHB gene (R170H, Q346R) cause the classic form of maple syrup urine disease (MSUD)","volume":"498","author":"Wang","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.ejpn.2015.07.009_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ymgme.2012.05.023","article-title":"Analysis of gene mutations in Chinese patients with maple syrup urine disease","volume":"106","author":"Yang","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"6","key":"10.1016\/j.ejpn.2015.07.009_bib19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10545-007-0579-x","article-title":"Description of the mutations in 15 subjects with variant forms of maple syrup urine disease","volume":"30","author":"Flaschker","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejpn.2015.07.009_bib20","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s10545-006-0315-y","article-title":"Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease","volume":"29","author":"Simon","year":"2006","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.ejpn.2015.07.009_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2004.11.010","article-title":"Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification","volume":"84","author":"Heldt","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejpn.2015.07.009_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1695-4033(07)70651-3","article-title":"Advances in the diagnosis and treatment of maple syrup urine disease: experience in Galicia (Spain)","volume":"67","author":"Couce Pico","year":"2007","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.ejpn.2015.07.009_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/8904_2011_69","article-title":"Cerebral edema in maple syrup urine disease despite newborn screening diagnosis and early initiation of treatment","volume":"3","author":"Myers","year":"2012","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ejpn.2015.07.009_bib24","series-title":"Protocolos de diagn\u00f3stico y tratamiento de los Errores Cong\u00e9nitos del Metabolismo AECOM","first-page":"17","article-title":"Protocolo de diagn\u00f3stico y tratamiento de la enfermedad de jarabe de arce","author":"Dalmau Serra","year":"2007"},{"key":"10.1016\/j.ejpn.2015.07.009_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001577-199801020-00002","article-title":"Validity of the gross motor function measure","volume":"10","author":"Bjornson","year":"1998","journal-title":"Pediatr Phys Ther"},{"key":"10.1016\/j.ejpn.2015.07.009_bib26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/humu.9428","article-title":"Mutational spectrum of maple syrup urine disease in Spain","volume":"27","author":"Rodr\u00edguez-Pombo","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ejpn.2015.07.009_bib27","doi-asserted-by":"crossref","first-page":"13110","DOI":"10.1074\/jbc.273.21.13110","article-title":"Impaired assembly of E1 decarboxylase of the branched-chain alpha-ketoacid dehydrogenase complex in type IA maple syrupurinedisease","volume":"273","author":"Wynn","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejpn.2015.07.009_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/humu.9187","article-title":"Identification of twelve novel mutations in patientswithclassic and variantforms of maple syrupurinedisease","volume":"22","author":"Henneke","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ejpn.2015.07.009_bib29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1086\/316950","article-title":"Gene preference in maple syrup urine disease","volume":"68","author":"Nellis","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejpn.2015.07.009_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s100380050047","article-title":"Molecular basis of intermittent maple syrupurinedisease: novel mutations in the E2 gene of the branched-chain alpha-ketoacid dehydrogenase complex","volume":"43","author":"Tsuruta","year":"1998","journal-title":"J Hum Genet"},{"key":"10.1016\/j.ejpn.2015.07.009_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0925-4439(97)00046-X","article-title":"Two new mutations in the human E1 beta subunit of branched chain alpha-ketoacid dehydrogenase associated with maple syrup urine disease","volume":"1361","author":"McConnell","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejpn.2015.07.009_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2007.04.011","article-title":"Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells","volume":"260","author":"Funchal","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ejpn.2015.07.009_bib33","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1172\/JCI67217","article-title":"Biochemical correlates of neuropsychiatric illness in maple syrup urine disease","volume":"123","author":"Muelly","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejpn.2015.07.009_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/8904_2011_105","article-title":"Clinical and biochemical profiles of maple syrup urine disease in Malaysian children","volume":"5","author":"Yunus","year":"2012","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ejpn.2015.07.009_bib35","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/mds.23629","article-title":"Movement disorders in adult surviving patients with maple syrup urine disease","volume":"26","author":"Carecchio","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.ejpn.2015.07.009_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00726-012-1330-y","article-title":"Large neutral amino acids: dietary effects on brain neurochemistry and function","volume":"45","author":"Fernstrom","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejpn.2015.07.009_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ymgme.2009.12.007","article-title":"Classical maple syrup urine disease and brain development: principles of management and formula design","volume":"99","author":"Strauss","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejpn.2015.07.009_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1203\/01.pdr.0000190571.60385.34","article-title":"Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD","volume":"59","author":"Hoffmann","year":"2006","journal-title":"Pediatr Res"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379815001373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379815001373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T13:14:33Z","timestamp":1566998073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379815001373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1090379815001373"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2015.07.009","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2015.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}